Coronary

For Most Patients, Only Spontaneous MI Is Relevant

6 min.

Novel Approaches to Reduce and Reverse Bleeding in Complex PCI

8 min.

The Importance of Addressing Lipids in Patients With Complex PCI

8 min.

Periprocedural MI Matters to All Patients!

4 min.

Does It Matter What Stent I Use in a HBR Patient?

8 min.

New and Emerging Pharmacology for ACS: Lipid Modulation and Anti-Inflammatory Agents

8 min.

My Roadmap for Preprocedure and Intraprocedural Antithrombotic Therapy in Complex PCI

8 min.

New and Emerging Pharmacology for ACS: Factor XI Inhibition

6 min.

PCI in Patients With AF: The Risk and Benefit of Antithrombotic Therapy

7 min.

P2Y12 Inhibitors in ACS: Which Agent in Which Patient and When?

7 min.

Short DAPT or De-Escalation After ACS

7 min.

Does Bleeding Risk Outweigh Thrombotic Risk or Vice Versa?

8 min.